4.5 Article

Ki-67 expression reveals strong, transient influenza specific CD4 T cell responses after adult vaccination

Journal

VACCINE
Volume 30, Issue 31, Pages 4581-4584

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2012.04.059

Keywords

Ki-67; Influenza vaccine; CD4 T cell

Funding

  1. NIH [HHSN272201000055C, N01-AI-50020, HHSN266200700008C, R01 AI069351]

Ask authors/readers for more resources

Although previous studies have found minimal changes in CD4 T cell responses after vaccination of adults with trivalent inactivated influenza vaccine, daily sampling and monitoring of the proliferation marker Ki-67 have now been used to reveal that a substantial fraction of influenza-specific CD4 T cells respond to vaccination. At 4-6 days after vaccination, there is a sharp rise in the numbers of Ki-67-expressing PBMC that produce IFN-gamma, IL-2 and/or TNF alpha in vitro in response to influenza vaccine or peptide. Ki-67(+) cell numbers then decline rapidly, and 10 days after vaccination, both Ki-67(+) and overall influenza-specific cell numbers are similar to pre-vaccination levels. These results provide a tool for assessing the quality and quantity of CD4 T cell responses to different influenza vaccines, and raise the possibility that the anti-influenza T cell memory response may be qualitatively altered by vaccination, even if the overall memory cell numbers do not change significantly. (C) 2012 Published by Elsevier Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available